Clinical trials referenced in this document:
Documents that mention this clinical trial
Short-duration dynamic [18F]DCFPyL PET and CT perfusion imaging to localize dominant intraprostatic lesions in prostate cancer: validation against digital histopathology and comparison to [18F]DCFPyL PET/MR at 120 minutes
Funding for this research was provided by:
canada foundation of innovation (Leading-Edge Fund)
ontario institute for cancer research
canadian institutes of health research
Received: 22 June 2021
Accepted: 27 September 2021
First Online: 15 October 2021
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee (University of Western Ontario Research Ethics Boards) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: All research participants consent to publication of data acquired in the approved study.
: Informed consent was obtained from all individual participants included in the study.
: The CT perfusion software is licensed to GE Healthcare (Ting-Yim Lee). All other authors have no competing interests to report.